Marc S.
- Country
- France
- Department
- Neurology
Research Overview
- Evaluation of Metformin and Temozolomide with Radiotherapy in Newly Diagnosed IDH Wild-Type Glioblastoma Grade 4 Patients
- Phase II Randomized Study of [177Lu]Lu-DOTATATE in Recurrent Meningioma Lacking Surgical or Radiotherapeutic Options
- Evaluation of Alpelisib and Trametinib Combination Therapy in Patients with Progressive Refractory Meningiomas
Data & Insights
Has run more than one trial at 2 of 35 partner sites.
Specializations
Neuro-Oncology
This investigator specializes in treating complex brain tumors, with particular emphasis on meningiomas and glioblastoma. Their research encompasses innovative therapeutic approaches for both primary and recurrent brain tumors.
- Progressive Refractory Meningiomas
- Recurrent Meningioma Management
- Grade 4 Glioblastoma Treatment
The investigator focuses on developing targeted treatment strategies for patients with limited therapeutic options.
Advanced Therapeutics
The research portfolio includes exploration of novel combination therapies and targeted treatments, including oxidative phosphorylation targeting and lutetium-based radiotherapy.
- Combination Drug Therapies
- Metabolic Treatment Approaches
- Radionuclide Therapy
Their work involves investigating metabolic pathways and molecular targeting in brain tumor treatment.
Treatment Innovation
The investigator explores multimodal treatment approaches, combining standard therapies with novel agents. Their work includes studies of radiotherapy combinations and targeted molecular therapies.
- Combined Modality Treatment
- Novel Drug Applications
- Personalized Medicine Approaches
Research focuses on developing alternative treatment options for patients with limited therapeutic choices.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.